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As one of the key nutrient sensors, insulin signaling plays an important role in integrating environmental
energy cues with organism growth. In adult organisms, relative insufﬁciency of insulin signaling induces
compensatory expansion of insulin-secreting pancreatic beta (β) cells. However, little is known about
how insulin signaling feedback might inﬂuence neogenesis of β cells during embryonic development.
Using genetic approaches and a unique cell transplantation system in developing zebraﬁsh, we have
uncovered a novel role for insulin signaling in the negative regulation of pancreatic progenitor cell
differentiation. Blocking insulin signaling in the pancreatic progenitors hastened the expression of the
essential β cell genes insulin and pdx1, and promoted β cell fate at the expense of alpha cell fate. In
addition, loss of insulin signaling promoted β cell regeneration and destabilization of alpha cell character.
These data indicate that insulin signaling constitutes a tunable mechanism for β cell compensatory
plasticity during early development. Moreover, using a novel blastomere-to-larva transplantation strat-
egy, we found that loss of insulin signaling in endoderm-committed blastomeres drove their differ-
entiation into β cells. Furthermore, the extent of this differentiation was dependent on the function of the
β cell mass in the host. Altogether, our results indicate that modulation of insulin signaling will be crucial
for the development of β cell restoration therapies for diabetics; further clariﬁcation of the mechanisms
of insulin signaling in β cell progenitors will reveal therapeutic targets for both in vivo and in vitro β cell
generation.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
Insulin is a crucial gluco-regulatory peptide hormone that is
produced by pancreatic beta (β) cells and released in proportion to
levels of circulating glucose. Under conditions of ﬂuctuating me-
tabolic demands and energy availability, the effective functional β
cell mass (insulin releasing capacity of the pancreas) is regulated
to match physiological demands through β cell compensation. The
failure of β cell compensation to meet insulin demand results in
diabetes mellitus, a metabolic disease of insufﬁcient insulin sig-
naling that is characterized by uncontrolled hyperglycemia and its
associated morbid complications. While compensation can be
transiently mediated in part via increased insulin production and
release from existing β cells, long term β cell compensationfor Pediatric Research in the
s and Metabolic Diseases, In-
e, Van Nuys Medical Sciences
.involves the expansion of β cell mass by multiple mechanisms
(Asghar et al., 2006; Wang et al., 2015; Weir and Bonner-Weir,
2004). For instance, in mice physiological stresses like over-nu-
trition and pregnancy can accelerate β cell replication (Kim et al.,
2010; Lee and Nielsen, 2009; Tanaka and Wands, 1996). However,
the replicative capacity of β cells varies widely among vertebrates
by species and age. The capacity of human β cells is lower than
that of most model organisms used to study replication (Kulkarni
et al., 2012). Furthermore, β cell replicative capacity diminishes
sharply after adolescence (Kulkarni et al., 2012; Linnemann et al.,
2014). In addition, using model organisms, β cells have been
shown to arise via neogenesis from non-β cell sources, including
differentiation from facultative progenitor cells and conversion
from other pancreatic endocrine cells (Bonner-Weir et al., 2010;
Chera et al., 2014; Chung et al., 2010; Thorel et al., 2010; Xu et al.,
2008; Ye et al., 2015). Stimulating β cell neogenesis and replication
in humans will be crucial for restoring β cell function and ulti-
mately curing diabetes. Thus, a comprehensive understanding of
the molecular mechanisms that sense insulin insufﬁciency and
translate it into β cell compensatory responses will impact the
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Several growth factors and cytokines have been shown to
regulate β cell replication in response to metabolic demand. In the
adult islet, insulin secreted by β cells has been shown to feedback
upon β cells to regulate islet size and β cell mass (Withers et al.,
1999). Activation of the insulin receptor triggers its autopho-
sphorylation, which is followed by downstream signal propagation
via the key effector Insulin Receptor Substrate 1/2 (IRS1/2)) to the
Akt and Mitogen Activated Protein Kinase (MAPK) pathways; these
pathways mediate many growth and metabolic responses (Siddle,
2011). Deletion of the insulin receptors in β cells (βIRKO) abolished
compensatory β cell mass expansion in adult mice and resulted in
hyperglycemia (Okada et al., 2007). Further, this suggests that
reported inﬂuences of glucose on β cell replication (Otani et al.,
2004) may be due in part to the indirect effects of augmenting
insulin secretion. Although much is known about replication-
mediated β cell mass compensation, little is known regarding the
cellular and molecular mechanisms of de novo neogenesis-medi-
ated β cell mass compensation.
It is likely that some mechanisms regulating β cell compensa-
tion via neogenesis are common to both the mature and devel-
oping pancreas, and the embryo is an especially amenable system
in which to study β cell formation. However, while the intrinsic
developmental programs regulating endocrine differentiation
have been very well characterized (Pan and Wright, 2011), the
extrinsic signals that control induction and differentiation of β
cells, as well as those signals that match β cell mass to the needs of
the embryo are less well understood. Among the pathways studied
are ﬁbroblast growth factor and Notch signaling, which suppress
differentiation of pancreas progenitors (Apelqvist et al., 1999;
Jensen et al., 2000; Norgaard et al., 2003) and epithelial growth
factor signaling, which inﬂuences β cell neogenesis (Cras-Méneur
et al., 2001; Miettinen et al., 2008; Suarez-Pinzon et al., 2005).
Surprisingly, the roles of the pancreatic hormones have not been
extensively studied during islet development. While glucagon
signaling has been shown to regulate alpha (α) cell mass by pro-
liferation, neogenesis, and cell fate switching mechanisms (Ye
et al., 2015; Gelling et al., 2003; Hayashi et al., 2009; Prasadan
et al., 2002), it is not clear whether other islet hormones like in-
sulin have a signiﬁcant role in the acquisition and stability of cell
fates in the developing islet. Even though the insulin signaling
pathway has been studied using mouse knockout models, the re-
sults from previous developmental studies appear contradictory.
Mice lacking the insulin receptor exhibit severe hyperglycemia at
birth despite the presence of normal islets (Accili et al., 1996; Joshi
et al., 1996; Kitamura et al., 2003). However, deletion of either or
both of the mouse insulin orthologues (Duvillié et al., 1997) or
downstream effectors such as Akt lead to marked islet hyperplasia
(Buzzi et al., 2010). Therefore, further investigation is required to
resolve how insulin signaling regulates β cell neogenesis during
development as well as in pathologies like diabetes.
Zebraﬁsh are a relevant and powerful system for the study of β
cell formation and homeostasis: they share key features of both
carbohydrate metabolism and their β cell differentiation program
with mammalian systems (Kinkel and Prince, 2009) while also
affording many experimental advantages (Grunwald and Eisen,
2002). As in mice and humans, the zebraﬁsh pancreas arises from
two discrete endodermal progenitor domains that fuse to establish
the architecture of the pancreas (Field et al., 2003; Jørgensen et al.,
2007; Pauls et al., 2007). In zebraﬁsh, the dorsal bud appears at
approximately 14 hours post fertilization (hpf) and gives rise ex-
clusively to differentiated endocrine cell types, which then cluster
to form the principal islet by 24 hpf. Emerging around 34 hpf, the
ventral bud engulfs the principal islet while differentiating into
both exocrine and endocrine cell lineages. In this study, we have
used zebraﬁsh to explore the role of insulin signaling duringembryonic β cell formation. Using genetic approaches in zebraﬁsh
that either inhibit insulin production or impair transduction
through the insulin signaling pathway, we have shown that insulin
signaling has an inhibitory role during early pancreas develop-
ment: loss of insulin signaling drove the precocious differentiation
of pancreatic progenitors into β cells. Using chimera analysis we
found that insulin signaling within the endoderm itself suppresses
β cell differentiation. Moreover, using a novel blastomere-to-larva
transplantation strategy, we found that loss of insulin signaling in
endoderm-committed blastomeres fostered their differentiation
into β cells, and that the extent of this differentiation was de-
pendent on the function of the host β cell mass. Taken together,
our data suggest that manipulation of the insulin signaling path-
way will be crucial for regenerative medicine approaches to dia-
betes therapies, including β cell differentiation from in situ pro-
genitors during regeneration, and from stem cells in vitro.2. Results
2.1. Intracellular blockade of insulin signaling promotes embryonic β
cell formation
To determine whether pancreatic progenitor cells are compe-
tent to receive insulin signals, we performed whole mount in situ
hybridization and quantitative PCR to evaluate the expression of
insulin receptors at key time points during pancreas development.
There are two isoforms of the zebraﬁsh insulin receptor, insulin
receptor a (insra) and insulin receptor b (insrb) (Toyoshima et al.,
2008). Both were strongly expressed in zygotes, indicating that
maternal contribution may affect early embryonic development
(Fig. 1A, Fig. S1A–B). Only insrb was expressed in the embryonic
pancreatic endoderm during early pancreas development, as vi-
sualized by co-localization with endoderm marker sox17 at 48
hours post fertilization (hpf) (Fig. 1B–C). In 108 hpf larvae, both
insra and insrb were expressed in the pancreas, liver and intestine,
which may reﬂect a metabolic role for insulin signaling during
later developmental stages (Fig. 1A, Fig. S1C–D′).
To investigate the inﬂuence of insulin signaling on β cell dif-
ferentiation, we generated a truncated mutant form of zebraﬁsh
IRS2 in which GFP is substituted for the C-terminal SH2-binding
domains, while retaining the N-terminal pleckstrin homology (PH)
and phosphotyrosine binding (PTB) domains (Fig. 2A; Fig. S2A). As
reported with similar constructs (Tanaka and Wands, 1996), this
mutant protein (hereafter dnIRS2-GFP) is expected to non-pro-
ductively bind to the insulin receptor and act as a dominant ne-
gative regulator of insulin signaling. Indeed, when dnIRS2-GFP
mRNA was injected into zygotes, we observed that dnIRS2-GFP
protein was enriched at the plasma membrane in 5 hpf embryos
(Fig. 2B,C) and remained expressed in the embryos through 24 hpf
(Fig. S2B). To determine whether this mode of insulin signaling
blockade affected the formation of β cells, we counted cells ex-
pressing insulin in dnIRS2-GFP mRNA-injected embryos at 24 hpf.
Relative to controls, we observed a 32% increase in the number of
insþ β cells marked by dsRed in Tg(insa:dsRed) embryos (Fig. 2D–
F). Previous studies have shown that homeodomain transcription
factor Pdx1 is essential for β cell differentiation and fate main-
tenance (Ahlgren et al., 1998; Jonsson et al., 1994; Ofﬁeld et al.,
1996). These roles of Pdx1 are conserved in zebraﬁsh during β cell
formation (Kimmel et al., 2011; Yee et al., 2001). We therefore
checked the expression of pdx1 in dnIRS2-GFP injected embryos;
consistent with the increased β cell quantity, we observed a
marked increase in pdx1 expression in the pancreatic region at
24 hpf (Fig. S2C,D). Concordantly, blockade of the Akt branch of
insulin signaling via treatment with the PI3 kinase inhibitor
wortmannin (Standaert et al., 1996) also resulted in increased β
Fig. 1. Expression of insulin and insulin receptors during zebraﬁsh endoderm development. (A) In situ hybridization for insra and insrb in the developing zebraﬁsh embryos.
(B–C) Fluorescent in situ hybridization of insrb (red) in Tg(sox17:GFP) endoderm (green) at 48 hpf. Abbreviations: z, zygote; ed, endoderm; p, pancreas; li, liver; in, intestine.
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embryos (Fig. 2G–I). In contrast, blockade of the MAPK pathway
via the Erk inhibitor U0126 (Favata et al., 1998) did not sig-
niﬁcantly inﬂuence β cell quantity at this stage (Fig. S2E–G). Taken
together, these data indicate that the excess β cell differentiation
induced by insulin signaling deﬁciency may be primarily regulated
via the Akt/PI3K branch of the insulin signaling pathway.
Next, we generated a transgenic model based on the HOT-Cre
system (Hesselson et al., 2009) that conditionally mis-expresses
dnIRS2-GFP; this permits inducible and sustained knockdown of
insulin signaling. This transgenic line, Tg(hs:loxp-mcherry-stop-
loxp-dnIRS2-GFP;cryaa:CFP), was crossed with Tg(hs:Cre) (Le et al.,
2007) to generate double transgenic embryos in which heat shock
induces ubiquitous expression of dnIRS2-GFP (Fig. 3A); these
double transgenic ﬁsh are hereafter termed HOT:dnIRS2 for sim-
plicity. Embryos bearing Tg(hs:loxp-mcherry-stop-loxp-dnIRS2-GFP;
cryaa:CFP) alone, without Cre, were used as the control group. We
veriﬁed the efﬁciency of insulin signaling blockade in HOT:dnIRS2
embryos at 54 hpf with an immuno-blot for phospho-Akt protein:
after multiple heat shocks at 10, 24, 28, 32, 36, and 48 hpf the HOT:
dnIRS2 embryos showed a 65% relative decrease in phosphorylated
Akt as compared with controls (Fig. 3B). Importantly, we detected
GFP ﬂuorescence only after heat shock induction, and the induced
dnIRS2-GFP appeared ubiquitous (see Fig. 3C,D,F,G; Fig. S3A″,B″).
Next, we used HOT:dnIRS2 transgenic zebraﬁsh to analyze islet
development. As with both prior approaches—dnIRS2 mRNA in-
jection and PI3K inhibitor treatment—the HOT:dnIRS2 double
transgenic embryos showed increased β cell quantity at 54 hpf
when heat shocked as above (Fig. 3C–E). Interestingly, we also
noted a signiﬁcant decrease in the number of glucagonþ α cells(Fig. 3C–E). We also examined Pdx1 protein distribution after mis-
expression of dnIRS2. In control 24 hpf embryos, Pdx1 was ex-
pressed predominantly in dorsal endocrine cells and weakly in
adjacent pancreatic endoderm (Fig. 3F,F′); however, in HOT:dnIRS2
embryos that were heat shocked at 10 hpf, Pdx1 expression was
strongly increased in both the principal islet (arrows) and the
adjacent pre-pancreatic endoderm (arrowheads, Fig. 3G,G′). This
result suggests that an increased Pdx1 expression domain in the
ventral pancreatic endoderm precedes the early differentiation of
ventral progenitor cells into β cells. Taken together, our genetic
and pharmacological data indicate that insulin signaling blockade
results in the following phenotypes: increased Pdx1 expression,
increased formation of β cells, and decreased generation of α cells.
2.2. Knockdown of insulin drives the early differentiation of β cells
To further delineate the mechanisms of insulin signaling in
pancreatic progenitor differentiation and β cell development, we
used splice-blocking morpholinos (MOs) to knockdown insulin
during embryogenesis. First, a MO targeting the exon 2-intron
2 boundary was used to disrupt zygotic insulin a (hereafter insa)
pre-mRNA splicing (Fig. S4A). Injection of insa MO (insaMO) re-
sulted in two aberrant splicing products of insa pre-mRNA, de-
monstrating its efﬁcacy (Fig. S4B–D); however, no general devel-
opmental defects were observed in insaMO-injected embryos (Fig.
S4E). Using immunoﬂuorescent staining, we observed a sustained
absence of insulin protein in insaMO-injected β cells at 72 hpf and
96 hpf (Fig. S5). Finally, to conﬁrm the speciﬁcity of our insaMO-
mediated knockdown, we co-injected an mRNA encoding Insulin a
protein with the insaMO. In embryos at 24 hpf, we found that the
Fig. 2. Insulin signaling blockade increases embryonic β cell formation. (A) Schematic of a dominant negative IRS2 construct designed to block transmission of insulin
signaling; C-terminal effector binding domains are replaced with GFP. (B,C) 5 hpf embryo injected with dnIRS2-GFP mRNA (B) Photomicrograph of epiﬂuorescence shows
ubiquitous distribution of GFP. (C) Confocal plane shows the localization of dnIRS2-GFP to the plasma membrane while co-injected H2B-RFP mRNA labels cell nuclei red. (D,
E) Confocal projections of control (D) and dnIRS2-GFPmRNA-injected islets in 24 hpf Tg(ins:dsRed) embryos. (F) Quantiﬁcation of insa:dsRedþ β cells in 24 hpf control (n¼12)
and dnIRS2-GFPmRNA injected embryos (n¼10). (G,H) Confocal projections of DMSO-treated control (G) and 1 mM wortmannin-treated islets in 30 hpf Tg(ins:CFP-NTR)
embryos. (I) Quantiﬁcation of β cells in DMSO-treated control (n¼18) and 1 μM wortmannin-treated (n¼17) islets in 30 hpf embryos. Student t-test was used to determine
signiﬁcance in F and I.
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“rescued” to normal levels (Fig. S6C–D).
Due to genomic duplication, zebraﬁsh have a second ortholo-
gue of insulin, insulin b (insb) (Papasani et al., 2006). In contrast to
the two murine Insulin paralogues that are expressed nearly
identically (Duvillié et al., 1997; Leroux et al., 2001; Soares et al.,
1985), the expression patterns of zebraﬁsh insulin paralogues dif-
fer signiﬁcantly. Speciﬁcally, while insa is expressed only in pan-
creatic β cells, insb is widely expressed, particularly in the head
and somatic musculature; this suggests that in zebraﬁsh the two
insulin genes execute distinct developmental functions (Papasani
et al., 2006). To test this hypothesis, we knocked down insb using a
MO that targeted the exon 4-intron 4 boundary (Fig. S7A). In in-
sbMO-injected embryos we observed efﬁcient disruption of insb
splicing (Fig. S7B) and severe developmental defects, including
microcephaly and shortening of the antero-posterior axis (Fig.S7C). We observed no change in insa splicing in insbMO-injected or
insb splicing in insaMO-injected embryos (Fig. S7D,E). Further-
more, insbMO injection affected neither the expression of insulin
protein in the islet, nor the number of pancreatic β cells (Fig. S7F–
H).
Next, we examined β cell formation during development in
insa-deﬁcient embryos. For this, we analyzed the differentiation of
β cells from both progenitor cell sources: the dorsal (early) and
ventral (late) pancreatic buds. β cells derived from each pancreatic
bud can be distinguished using a label retaining cell (LRC) assay
(Hesselson et al., 2009) in which embryonic cells are initially
uniformly labeled by zygotic injection of H2B-RFP mRNA. As de-
velopment proceeds, the ﬂuorescence intensity of the encoded
ﬂuorescent protein is diluted by mitosis. Differences in H2B-RFP
signal strength among cell populations reﬂect differences in their
proliferative histories. The dorsal bud-derived β cells (DBCs),
Fig. 3. Inducible genetic blockade of insulin signaling promotes β cell formation. (A) Schematic of genetic insulin signaling blockade strategy. In double transgenic embryos,
heat shock induces Cre expression and recombination of the mCherry-switch-dnIRS2-GFP transgene as well as expression of the recombined dnIRS2-GFP transgene.
(B) Immunoblot of pi-Akt in Cre-negative control versus Cre-positive embryos showing that induction of dnIRS2-GFP effectively blocks insulin signaling. (C,D) Confocal
planes of 54 hpf control and HOT:dnIRS2 islets stained for GFP (green), Insulin (red), and Glucagon (white). Embryos were heat shocked repeatedly, at 10, 24, 28, 32, 36, and
48 hpf; dnIRS2-GFP was induced ubiquitously, but only in Cre-positive HOT:dnIRS2 embryos. (E) Quantiﬁcation of Insulinþ β cells and Glucagonþ α cells in control (gray,
n¼8) and dnIRS2-expressing HOT:dnIRS2 (red, n¼6) groups. (F–G′) Merged and single channel confocal projections of 24 hpf control and HOT:dnIRS2 pancreatic endoderm
stained for GFP (green) and Pdx1 (red). dnIRS2-GFP is induced ubiquitously in HOT:dnIRS2 embryos, which show expanded Pdx1 protein expression in the principal islet
(arrows) and adjacent ventral endoderm (arrowheads). Student t-test was used in B and two-way ANOVA was used in E to determine signiﬁcance.
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positive. In contrast, ventral bud-derived progenitor cells lose
H2B-RFP signal via extensive proliferation before ventral bud-de-
rived β cells (VBC) differentiate. Using this approach we quantiﬁed
the number of DBCs and VBCs in insaMO-injected pancreata
throughout development. We found that only DBCs were present
in the principal islet of control embryos at 24 hpf—consistent with
our previous ﬁndings (Ye et al., 2015; Hesselson et al., 2009)—and
that insaMO did not inﬂuence DBC number (Fig. 4A–G). In contrast,
H2B-RFP-negative VBCs were detected after 48 hpf and continued
to increase throughout development (Fig. 4H). Strikingly, a sig-
niﬁcant number of precocious H2B-RFP-negative VBCs were de-
tected in insaMO-injected embryos at 24 hpf (Fig. 4D,H). Similarly,
we found that treatment with the PI3K inhibitor wortmannin also
increased VBC but not DBC formation (Fig. S8). We excluded the
possibility that these precocious VBCs were derived from hyper-
proliferative DBCs since both phospho-histone H3 (PHH3) im-
munoﬂuorescence and EdU DNA incorporation assays revealed noproliferation in control or insaMO-injected pancreata at 24 hpf
(Fig. S9A–D″). These data support the interpretation that the ex-
cess VBCs in insaMO-injected embryos arose by neogenesis from
ventral bud sources. Concordantly, in 24 hpf insaMO-injected
pancreata, but not in control pancreata, ectopic Pdx1þ cells were
detected in the ventral endoderm (Fig. S10A–D′).
However, despite the early increase in VBCs, we found that the
total β cell quantity in insaMO-injected embryos had normalized
and was indistinguishable from controls at 72 and 96 hpf (Fig. 4H)
even though Insulin protein was still undetectable (Fig. S5). Simi-
larly, HOT:dnIRS2 embryos that were received daily heat shocks
also normalized their β cell mass by 96 hpf (Fig. S3C). Together,
these results suggest that normalization of β cell mass after an
early differentiation of β cells is not as a result of a particular ex-
perimental mode of insulin signaling blockade, but rather is likely
to be biologically relevant. These data support the interpretation
that insulin expression and release from the early pancreatic islet
feeds back to inhibit precocious differentiation of β cells from the
Fig. 4. Insulin knockdown increases Pdx1 expression and drives early pancreatic progenitor differentiation into β cells. (A–F) Confocal projections of 24 hpf, 48 hpf, and
80 hpf Tg(insa:CFP-NTR) control (A–C) and insaMO-injected (D–F) islets that were co-injected with H2B-RFP mRNA to distinguish dorsal (H2B-RFP-positive DBCs) and ventral
(H2B-RFP-negative VBCs) bud-derived β cells. Islets were immuno-stained for CFP (β cells, green) and insulin (blue). Insulin protein was not detectable in insaMO-injected
islets. (G,H) Quantiﬁcation of H2B-RFP-positive DBCs (G) and H2B-RFP-negative VBCs (H) in control (black line) and insaMO-injected (red line) islets from 24 hpf to 96 hpf
(nZ8 islets at each stage). VBC count is increased early at 24 and 48 hpf, but normalizes to control levels by 72 hpf. (I–L) In situ hybridization of pdx1 expression in 24 hpf
and 48 hpf control (I,J) and insaMO-injected (K,L) embryos. pdx1 expression was increased in the principal islet (arrow) and adjacent endoderm (arrow heads). (M) Real time
PCR to detect Pdx1 expression in both control and insaMO-injected embryos from 24 hpf to 96 hpf (n¼3). (N,O) Confocal planes of 41 hpf Tg(ptf1a:GFP) control (N) and
insaMO-injected (O) endoderm stained for GFP (green) and Pdx1(red). Pdx1 expression was increased while ptf1a:GFP expression was decreased in insaMO-injected embryos.
(P) Quantiﬁcation of double positive Pdx1þ ptf1aþ pancreatic progenitor cells in both control (n¼6) and insaMO (n¼6) injected embryos. Abbreviations: pi, principal islet;
vp, ventral pancreas. ANOVA was used in G,H, and O and Student's t-test was used in P to determine signiﬁcance.
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ther may inﬂuence the total β cell mass between 24 and 72 hpf.
To analyze the mechanisms underlying insulin-directed pan-
creatic progenitor differentiation, we analyzed the expression of
Pdx1 in both control and insaMO-injected embryos. In 24 hpf
embryos, Pdx1 expression was strongly expressed in the principal
islet; at 48 hpf after the induction of the ventral pancreatic bud,
Pdx1 was expressed in both the principal islet and adjacent en-
doderm (Fig. 4I,J). After insaMO knockdown, we observed in-
creased Pdx1 expression in the principal islet region (Fig. 4K,L,
arrow), which is consistent with our interpretation that a reduc-
tion of insulin drives excess β cell differentiation from the ventral
pancreas. In addition, insaMO also promoted ectopic pdx1 ex-
pression in the adjacent endoderm from which the ventral pan-
creatic progenitor cells are derived (Fig. 4K–L, arrowheads). An
increase in Pdx1 expression at early stages of pancreas develop-
ment (24 and 48 hpf), but not during later stages (72 and 96 hpf)
was conﬁrmed by quantitative PCR (Fig. 4M).
Expression of Pdx1—together with the transcription factor
Ptf1a—deﬁnes the pancreatic progenitor domain in mammals
(Burlison et al., 2008). During zebraﬁsh early ventral bud devel-
opment we performed immunoﬂuorescent staining of Pdx1 in Tg
(ptf1a:EGFP)jh1 embryos at 41 hpf. We found that all Ptf1a-positive
cells in the ventral pancreatic endoderm were also Pdx1-positive
(Fig. 4N, inset); suggesting that these are the equivalent of mam-
malian multipotent pancreatic progenitor cells. This interpretationis concordant with ptf1a lineage tracing studies in zebraﬁsh (Wang
et al., 2015). We next asked how loss of insulin affected develop-
ment of this progenitor domain in our model. In sharp contrast to
the expansion of the Pdx1þ domain observed with insaMO
knockdown, pancreatic ptf1a:GFP expression was decreased after
insaMO knockdown, as was the number of double positive Pdx1þ
ptf1a:GFPþ pancreatic progenitors (Fig. 4O,P). These ﬁndings in-
dicate that knockdown of insulin induces early differentiation of
progenitor cells into β cells, which consequently diminishes the
ventral pancreatic progenitor cell pool. In accord with this ﬁnding,
we also observed decreased exocrine pancreas size in insaMO-in-
jected larvae (data not shown). Overall, our ﬁndings suggest that
insulin signaling is part of a feedback loop through which newly
formed β cells govern the ongoing differentiation of the pancreatic
progenitor cells. As such, the loss of insulin induces a compensa-
tory increase of β cell differentiation during early islet
development.
2.3. Knockdown of insulin induces ectopic Pdx1 expression in α cells
and destabilizes α cell fate
We next investigated how insulin signaling impacts speciﬁca-
tion of other endocrine cell types during development. First, α
cells were examined by immunoﬂuorescent staining of glucagon
in insaMO-injected islets. Characteristically, α cells are located in
the islet mantle and β cells are clustered in the islet core in both
Fig. 5. Insulin knockdown impairs α cell development and destabilizes α cell fate. (A,B) Confocal projections of 100 hpf Tg(insa:CFP-NTR) control (A) and insaMO-injected
(B) islets stained for Glucagon (red) and CFP (β cells, green). α cell count is decreased and α/β cell architecture is inverted. (C) Quantiﬁcation of Glucagon-positive cells in
54 hpf, 80 hpf and 100 hpf control (gray) and insaMO-injected (red) islets (nZ 5 for all time points except 54 hpf control, n¼3). (D–E′) Confocal projections (D,E) and
confocal planes (D′,E′) of 2 months post fertilization (mpf) control (D,D′) and insaMO-injected (E,E′) islets stained for Glucagon (red), Insulin (green) and DNA (blue).
Reduction of α cell mass was sustained into adult stages. (F,G) Confocal planes of 100 hpf control (F) and insaMO-injected (G) islets immunostained for Glucagon (white) and
Pdx1 (red). Double positive Glucagonþ Pdx1þ cells (arrows) were increased with insaMO-injection. (H) Quantiﬁcation of double positive Glucagonþ Pdx1þ cells in 100 hpf
control (n¼6) and insaMO-injected (n¼10) islets. Two way ANOVA was used in C and Student's t-test was used in H to determine signiﬁcance.
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organization of islet cells in the insaMO-injected larvae: in insaMO-
injected islets, the islet architecture was inverted such that there
was a core of glucagonþ α cells was surrounded by insulinþ β
cells (Fig. 5A,B; Fig. S11). As observed in HOT:dnIRS2 embryos
(Fig. 3E), insaMO-injected islets also contained a decreased num-
ber of α cells at 54–100 hpf (Fig. 5C). Moreover, we found that the
impaired α cell development in the insaMO-knockdown embryos
persisted in adulthood at 2 months post fertilization (Fig. 5D–E′).
In contrast to the α cell population, there was no signiﬁcant
change in the number of somatostatinþ delta (δ) cells (Fig. S12A–
C). Also, the total endocrine cell number, as marked by Tg(neurod:
GFP), only slightly increased in 24 hpf insaMO-injected embryos,
but was unchanged at 2, 3, and 4 dpf (Fig. S12D–L). Together, these
data indicate that part of the increased β cell mass may come at
the expense of α cell fate in insulin-deﬁcient embryos.
To test this interpretation, we ﬁrst examined the expression ofPdx1 in the α cells of control and insaMO-injected islets. In in-
saMO-injected islets Pdx1 expression was often aberrantly co-ex-
pressed in glucagonþ α cells (Fig. 5F–H and S13A–E); this suggests
that α cell maturation fails and that α cell identity is destabilized.
Indeed α cells exhibit a degree of plasticity during development
and regeneration. For instance, in zebraﬁsh (Ye et al., 2015) and
mouse (Chung et al., 2010; Thorel et al., 2010) models of extreme β
cell ablation, α cells can spontaneously transdifferentiate into β
cells through an intermediate Pdx1þ Glucagonþ stage. Further-
more, mis-expression of Pdx1 induces α cell fate instability and
results in α to β transformation in some contexts (Yang et al.,
2011). Based on this, we hypothesized that ectopic Pdx1 expres-
sion in α cells of insaMO-injected islets would result in the in-
stability of α cell identity, particularly during β cell regeneration.
To test this, we ablated β cells in Tg(insa:CFP-NTR)s892 embryos
using metronidazole (Curado et al., 2007; Pisharath et al., 2007)
and allowed islets to recover for one day (Fig. 6A). In regenerating
Fig. 6. Insulin knockdown enhances regeneration of β cells. (A) Schematic of β cell ablation and regeneration experiments. Control and insaMO-injected insa:CFP-NTR
embryos were treated with MTZ from 52 to 80 hpf, recovered in fresh egg water for 1 day, and analyzed at 100 hpf (1 day post ablation; dpa). (B–C′) Merged (B,C) and
single channel (B′,C′) confocal projections of regenerated 100 hpf control (B,B′) and insaMO-injected (C,C′) islets immunostained for Gcg (red), CFP (β cells, green), and DNA
(blue). Arrows indicate the expansion of strongly double positive Insþ Gcgþ cells. (D–E′) Merged (D,E) and single channel (D′,E′) confocal projections of 100 hpf control (D,D
′) and insaMO-injected (E,E′) islets immunostained for CFP (green) and DNA (blue). All islets expressed zygotically-injected H2B-RFP (red) to mark DBCs. Arrows indicate the
expansion of double positive H2B-RFPþ Insþ cells; this indicates conversion of non-β endocrine cells into β cells. (F) Quantiﬁcation of insaþ , Gcgþ , and insaþ Gcgþ cells in
1 dpa control (n¼17) and insaMO-injected (n¼22) islets. (G) Quantiﬁcation of H2B-RFPþ insaþ and H2B-RFP- insaþ regenerating β cells in 1 dpa control (n¼17) and
insaMO-injected (n¼13) islets. Student's t-test was used in G to determine statistical signiﬁcance.
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either CFP-NTRþ (β cells), Glucagonþ (α cells), or bihormonal
CFP-NTRþ Glucagonþ . In insa knockdown islets we observed in-
creased β cell regeneration, and many regenerated β cells were co-
labeled with Glucagon (Fig.6B–C′,F). To distinguish between the
possibilities that these double positive cells had formed by (1) de
novo neogenesis, or (2) the transdifferentiation of Glucagonþ α
cells, we used the LRC assay, in which all early differentiated en-
docrine cells (o40 hpf) in the principal islet are labeled. In this
experiment, a cell of any endocrine subtype that transdiffer-
entiated into a β cell during regeneration would have been labeled
with H2B-RFP, while those that arose by de novo neogenesis would
have been unlabeled (Ye et al., 2015). Consistent with our inter-
pretation of α to β cell transdifferentiation, we found that the β
cell ablated insaMO-injected islets showed a 2.5-fold increase of
regenerated H2B-RFP-positive β cells, but no change in thequantity of regenerated H2B-RFP-negative β cells (Fig. 6D–E′,G). As
a second test of α cell transdifferentiation, we also performed
genetic α cell lineage tracing using the HOTcre system. Speciﬁcally,
through combination of the transgenic lines Tg(gcga:Cre)s962 and
Tg(hsp70l:loxp-mcherry-stop-loxp-H2B-GFP;cryaa:CFP)s923, α cells
were labeled with H2B-GFP by heat-shock before β cell ablation
(Ye et al., 2015). In these islets, if α cell identity was lost during β
cell regeneration, then pre-labeled α cells would be detectable as
both glucagon-negative and H2B-GFP-positive. Indeed, in insaMO-
injected embryos we found that a signiﬁcant population of α cells
pre-labeled in this fashion lost glucagon expression during β cell
regeneration (Fig. S13F–H); thus α cell plasticity appears to in-
crease after insulin knockdown. The loss of glucagon expression
could indicate that α cells have de-differentiated, or have been
converted into another endocrine cell type; however, we hy-
pothesize that α to β cell conversion predominates after loss of
Fig. 7. Insulin signaling blockade in transplanted endodermal committed blastomeres promotes Pdx1 expression. (A) Scheme of endoderm replacement transplantation
experiments. sox32-injected blastomeres termed “Endoderm Committed Blastomeres” (ECBs) were isolated from donor Tg(sox17:GFP) blastulae with or without injected
dnIRS2-GFP mRNA. ECBs were transplanted into endoderm deﬁcient, sox32MO-injected host blastulae. (B) 24 hpf chimera shows extensive replacement of endogenous
endoderm with transplanted Tg(sox17:GFP) donor cells. (C–D″) Merged and single channel confocal projections of 24 hpf embryos with endoderm transplants from sox32
mRNA (C–C″, n¼8) or sox32 and dnIRS2 mRNA (D–D″, n¼7) injected donors. Embryos were immunostained for GFP (green), Pdx1 (red), and DNA (blue). dnIRS2-GFP-
expressing endoderm showed increased Pdx1 expression.
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transdifferentiation after β cell ablation in zebraﬁsh (Ye et al.,
2015). In summary, we have demonstrated that blocking insulin
signaling via insaMO decreases α cell formation and induces Pdx1
expression in α cells. Furthermore, the increased β cell regenera-
tion via α to β cell conversion in insaMO embryos may result from
instability of α cell fate and α to β cell conversion consequent to
diminished insulin signaling.
2.4. Loss of insulin signaling in transplanted blastomeres promotes β
cell formation
To distinguish whether the precocious β cell differentiationobserved in our insulin signaling-knockdown models was due
speciﬁcally to loss of insulin signaling in endodermal lineages, we
generated endodermal chimeras via blastomere transplantation.
Speciﬁcally, sox32 mRNA was injected into donor zygotes to drive
endoderm formation while sox32 MO was used to block host
embryo endoderm formation (Stafford et al., 2006). In these chi-
meras, transplanted donor cells (endoderm-committed blas-
tomeres; ECBs) replaced nearly all endodermal tissues in host
embryos (Fig. 7A–B). Thus, we generated chimeric embryos in
which endodermal gene expression could be independently ma-
nipulated. When we blocked insulin signaling in the transplanted
ECBs—by injection of dnIRS2-GFP mRNA into donor zygotes—we
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panded Pdx1þ domain identical to that seen with global dnIRS2
over-expression (Fig.7C–D″). This indicates that endodermal pro-
genitor cells directly respond to insulin signaling by limiting Pdx1
expression.
Overall, our data indicate that insulin signaling acts as a ne-
gative regulator in a developmental context, inhibiting the early
differentiation of ventral pancreatic progenitors. We next asked
whether blocking insulin signaling in transplanted multipotent
progenitor cells could promote their differentiation into β cells in a
more mature pancreatic setting. To approach this in a manner that
might have relevance to therapies involving stem cell transplan-
tation, we developed a novel blastula to larvae cell transplantation
assay (Fig. 8A,B). For this, blastomeres were collected from sox32
mRNA-injected donor blastula stage embryos; these ECBs were
transplanted into the pancreatic region in larval stage hosts, and
the survival and integration of donor endoderm into host tissuesFig. 8. Insulin signaling blockade in endodermal committed blastomeres promotes Pdx1
(insa:ﬂag-NTR) larva cell transplantation scheme. (B) 5 dpf host shows Tg(sox17:GFP) do
(green) host with transplanted Tg(ubi:zebrabow) donor cells (red) at 1 dpt shows engraf
generated with the following four combinations: (1) wild type ECBs (dnIRS2) into non
ECBs (dnIRS2) into β ablated host (n¼6); and (4) ECBs þdnIRS2 into β ablated host (n¼
GFP) donor ECBs (outlined) at 1 dpt, stained for GFP (green), Pdx1 (red), Alcam (white), an
E′) and β cell-ablated hosts (F–F′). Few transplanted ECBs expressed Pdx1. (G–H′) sox32
cell-ablated (H–H′) hosts. Loss of β cells increases Pdx1 expression in transplanted ECBs. S
p, pancreas; ib, intestine bulb; li, liver.was veriﬁed. RFP-expressing ECBs from Tg(ubi:zebrabow) embryos
were transplanted into Tg(kdrl:GFP) hosts with GFP-expressing
vasculature; blood vessels pervaded the transplanted donor tissue
in chimeras (Fig. 8C), demonstrating a close interaction between
the donor and host tissues. Approximately 80% of host embryos
(33 of 41) at one day post transplantation (dpt) had successfully
integrated the transplanted ECBs.
We next analyzed the differentiation of these transplanted
ECBs in the context of wild type or β cell-ablated hosts. First, we
found that control donor ECBs differentiated into sox17:GFPþ
endodermal cells by 1 dpt in wild type hosts; however, these ECBs
did not further differentiate into Pdx1þ cells. In contrast, β-cell-
ablated host larvae promoted the expression of Pdx1 in control
donor ECBs (Fig. 8D,E–F′), which demonstrates that the host β cell
mass inﬂuences the differentiation of transplanted donor ECBs at a
distance. Next, to test whether insulin was essential for this action,
dnIRS2 mRNA-injected donor cells—with impaired insulinexpression after transplantation into β-cell ablated hosts. (A) Blastula ECB to 4 dpf Tg
nor cells at 1 day post transplantation (dpt). (C) Confocal projection of Tg(kdrl:GFP)
tment. (D) Percentage of transplanted ECBs that are Pdx1-positive. Chimeras were
-ablated host (n¼4); (2) ECBs þdnIRS2 into non-ablated host (n¼6); (3) wild type
8). (E–H′) Merged and single channel confocal planes of chimeras showing Tg(sox17:
d DNA (blue). (E–F′) sox32mRNA-injected blastomeres transplanted into β intact (E′
and dnIRS2 mRNA-injected blastomeres transplanted into β cell-intact (G–G′) and β
tudent t-test was used for statistical analysis in D. Abbreviations: sb, swim bladder;
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a clear increase in Pdx1þ cell quantity; this increase was even
more striking in dnIRS2 donor ECBs that had integrated into β cell-
ablated chimeras (Fig. 8D,G–H′). Together, these results indicate
that insulin signaling intrinsically regulates Pdx1 expression in the
endodermal progenitor-like ECBs. Furthermore, these ECBs are
also inﬂuenced by β cell function at a distance.
Next, to determine whether donor ECBs can differentiate into
pancreatic endocrine cells, at 2 dpt we examined Insulin and
Glucagon protein expression. Neither hormone was detected in
donor cells that were transplanted into non-ablated host larvae
(data not shown); this is consistent with the minimal Pdx1 in-
duction observed in ECBs in a non-ablated host environment. In
contrast, when ECBs were transplanted into β cell-ablated host
larvae, these donor cells differentiated into both insulinþ cells and
glucagonþ cells (Fig. 9A–B‴, Fig. S14A–B′). Furthermore, when
dnIRS2 mRNA-injected ECBs were transplanted into β cell-ablated
hosts, there was a marked increase in the number of insulin-Fig. 9. Insulin signaling blockade in ECB donor cells promotes Insulin expression and h
transplanted Tg(sox17:GFP) donor ECBs in β cell-ablated host larvae stained for GFP (gree
D′) Higher magniﬁcation of boxed region in panels A–A′ and C–C′, respectively. In (A–B
zygotically-injected with sox32 and dnIRS2 mRNAs. Cells derived from the ECB transpl
indicated by a red arrow. (E) Quantiﬁcation of Insulinþ β cells in donor ECBs that were tr
insulin signaling with dnIRS2 increased the production of insulin-positive β cells. (F)
transplantation with no cells (sham control, n¼12), donor ECBs injected with sox32 mRN
for the role of insulin signaling in regulating β cell differentiation and reciprocal intera
vironment. Student's t-test was used in E and one-way ANOVA was used in F to deter
ablation.expressing cells in the transplant; in contrast, no glucagonþ cells
were detected (Fig. 9C–E, Fig. S14C,C’). This is concordant with our
earlier results that showed that inhibition of insulin signaling
impairs α cell differentiation. Interestingly, in addition to an in-
crease of β cell differentiation in dnIRS2 donor ECBs, we observed
transplanted dnIRS2 ECBs can inﬂuence host β cell regeneration as
well. We observed a signiﬁcant increase of β cells in the principal
islets of host larvae when they were transplanted with dnIRS2
donor ECBs (Fig. 9F, Fig. S15). In summary, we have demonstrated
that insulin signaling in transplanted endoderm-committed blas-
tomeres regulates Pdx1 expression and β cell formation both in
donor and host tissues.3. Discussion
The coordinated growth and development of the pancreatic β
cell mass involves many phases, including speciﬁcation andost β cell regeneration. (A–D′) Merged and single channel confocal projections of
n), Insulin (red) and Glucagon (white) at 2 days post transplantation (dpt). (B–B′, D–
′) donor cells were injected with sox32 mRNA only; in (C–D′) donor ECBs had been
ant are bounded by a dotted yellow line and the principal islet (pi) of the host is
ansplanted into β cell ablated hosts; dnIRS2 (n¼11), þdnIRS2 (n¼10). Blockade of
Quantiﬁcation of host-derived regenerated β cells in the principal islet (pi) after
A alone (n¼11), or ECBs injected with sox32 plus dnIRS2 mRNAs (n¼11). (G) Model
ctions between transplanted endoderm-committed blastomeres and the host en-
mine signiﬁcance. Abbreviation: pi, host larvae principal islet at 2 days post β cell
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ferentiation, and β cell proliferation. Here, we provide evidence
that insulin signaling acts as a negative feedback signal to regulate
pancreatic progenitor cell differentiation during development. We
have used multiple approaches to block insulin signaling—in-
cluding mis-expression of dominant negative pathway effectors,
knock down of insulin ligand with morpholinos, and small mole-
cule inhibitors—to show that this pathway regulates the neogen-
esis of both β cells and α cells. With loss of insulin signaling during
embryonic development, we observed increased Pdx1 expression,
a precocious differentiation of β cells, and a coordinated loss of α
cell identity. In addition, using a novel blastomere-to-larva trans-
plantation strategy, we found that loss of insulin signaling pro-
moted the differentiation of endoderm committed blastomeres
(ECBs) into β cells. Taken together, our data suggest that appro-
priate modulation of insulin signaling may be important for the
optimal generation β cells in vitro and in vivo, and thus may fa-
cilitate β cell replacement strategies for the treatment of diabetes.
3.1. A conserved role for insulin signaling in islet development
Our results in zebraﬁsh are consistent with a role for insulin as
a physiologically relevant signal that feeds back to regulate pan-
creas progenitor differentiation during the expansion of the β cell
mass. The release of active insulin from nascent functional β cells
would provide a direct means for progenitors to sense and inter-
pret embryonic requirements for β cells: matching β cell number
with changing physiological needs of the growing embryo. Con-
sistent with this, a comparable response was also observed in the
β cell mass of mutant mice lacking insulin expression. Although
loss of both mouse Insulin orthologues is required to induce hy-
perglycemia, islet hyperplasia was observed in the single Ins1 and
Ins2 knockouts, and double null mice (Duvillié et al., 1997). Indeed,
islet size is signiﬁcantly increased in Ins1 /Ins2 / mice at birth,
and the β cell mass in Ins2 / mice was increased almost three-
fold at 7 weeks of age, indicating that increased β cell mass ex-
pands to compensate for low insulin production (Duvillié et al.,
1997; Leroux et al., 2001). This is further supported by the ﬁnding
that expression of human INSULIN in the Ins1 /; Ins2 / mouse
reverses the compensatory β cell hyperplasia (Karaca et al., 2007).
These ﬁndings, together with our results, support the hypothesis
that insulin acts as a negative regulator for β cell formation during
development (Duvillié et al., 1997; Leroux et al., 2001).
In contrast to Insulin gene mutants, Insr / mice initially ap-
pear unaffected as neonates, showing a normal β cell mass (Accili
et al., 1996; Joshi et al., 1996). Moreover, immediately after feeding
severe insulin resistance in these mutants results in hyperglyce-
mia, hyperinsulinemia and neonatal death (Accili et al., 1996; Joshi
et al., 1996). On the surface, these data appear contrary to our
hypothesis. However, this contradictory result may be due to
compensatory/redundant activation of IGF-1 receptors in the ab-
sence of insulin receptors (Kitamura et al., 2003). Local production
of IGF-1 in the pancreas may act as negative regulatory factor of β
cell mass, as knockout of Igf1 in the pancreas increases β cell dif-
ferentiation and a 2.3-fold enlarged islet cell mass (Lu et al., 2004).
Thus, any de-repression of β cell differentiation resulting from loss
of insulin signaling through InsR is likely countered by redundant
activation of IGF1R signaling. On the other hand, our data does not
exclude the possibility that insulin regulates pancreatic progenitor
cell differentiation in part via activation of IGF1R, given the com-
plex interaction between the insulin and IGF1 signaling pathways
(Siddle, 2011; Kitamura et al., 2003). However, given that Insulin
binds the IGF1R and InsR/IGF1R heterodimers with much lower
afﬁnity than InsR (Pandini et al., 2002; Soos et al., 1993), it is likely
that our manipulations affect insulin receptor signaling rather
than IGF1R signaling. In further support of this interpretation,knockdown either of igf1 or igf1r in zebraﬁsh results in severe
neural and gross developmental defects (Eivers et al., 2004; Zou
et al., 2009), which are signiﬁcantly different from the insulin
knockdown phenotypes reported here. This supports our assertion
that the insulin receptor is the major member of the insulin re-
ceptor family that suppresses the differentiation of pancreas pro-
genitor cells.
In addition to a direct effect of insulin signaling on the differ-
entiation of pancreas progenitors, additional indirect actions are
also possible. For instance, in the absence of insulin signaling, we
expect that free glucose levels will be increased in developing
zebraﬁsh, as we have previously shown after β cell ablation (Ye
et al., 2015; Andersson et al., 2012). Glucose can act both as a β cell
mitogen (reviewed in Oh (2015)) and as a factor promoting de novo
β cell neogenesis/differentiation (Soggia et al., 2012; Guillemain
et al., 2007; Ninov et al., 2013). However, our transplantation ex-
periments intimate that glucose levels cannot mediate the differ-
entiation effect alone. First, in our endodermal chimeras, insulin
signaling, and thus glucose disposal, should be unaffected in all
non-endodermal tissues, including skeletal muscle; yet Pdx1 ex-
pression was clearly increased in dnIRS2-injected endoderm. The
heterochronic ECB transplants provide more convincing evidence:
in these, dnIRS2 induced the expression of Pdx1 even when host β
cells, and also carbohydrate metabolism, were unperturbed. These
data support a model in which insulin ligand signals the un-
differentiated endoderm directly. There are at least two explana-
tions for the additive effects of dnIRS2 expression in ECBs and host
β cell-ablation upon the differentiation of β cells. Most simply, the
loss of insulin release via β cell ablation could further depress the
insulin signaling knock down elicited by dnIRS2. Alternately, it
could result from the combined effects of decreased insulin sig-
naling and increased free glucose levels. The coordinated actions
of glucose and insulin would provide a integrated mechanism to
regulate differentiation of β cells, under varied physiological con-
ditions. Both insulin signaling (Nakae et al., 2002; Martinez et al.,
2006) and glucose sensation (Housley et al., 2008) can modulate
the activity of the Foxo1, a transcription factor that regulates the
expression of β cell characteristics (Talchai et al., 2012). Whether
molecular integration of both insulin and glucose sensing path-
ways is mediated by Foxo1 during β cell development and re-
generation is an exciting hypothesis that requires more study.
When we transplanted dnIRS2-expressing ECBs into zebraﬁsh
larvae, we also found that these pluripotent “insulin resistant”
blastomeres promoted β cell regeneration in host tissues. This may
reveal a bidirectional interchange between the ECB-derived pro-
genitors and their environment. This proposition is consistent
with previous studies that show that transplanted stem cells can
secrete angiogenic factors and growth factors (Gnecchi et al., 2008;
Horie et al., 2011). In fact, some functional beneﬁts observed after
stem cell transfer might be due in part to the secretion of soluble
factors that act as paracrine or endocrine fashion to promote tissue
regeneration (Gnecchi et al., 2008; Kono et al., 2014; Mirotsou
et al., 2007). Thus, we propose that in our model that the trans-
planted donor blastomeres interact through the release of secreted
signaling factors that act as paracrine or systemic signals (Fig. 9G).
Additional studies are needed to test this hypothesis and to
identify whether there are additional signaling factors besides
insulin and glucose; unveiling these mechanisms will be essential
for understanding the deﬁciencies of β cell compensation that are
seen in insulin-resistant and diabetic states.
3.2. Insulin signaling regulates endocrine subtype differentiation
during development and transdifferentiation during regeneration
In addition to regulating pancreatic progenitor cell differ-
entiation into β cells, our data also indicate that insulin plays a
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After blockade of insulin signaling we found an increase of β cell
formation from the pancreatic progenitor cells, and a decrease of α
cell fate. This function of insulin signaling is likely to be mediated
in part by its repressive actions on Pdx1, as our results show that
loss of insulin signaling promotes Pdx1 expression in glucagon
positive α cells as well as pancreas progenitor cells and trans-
planted endoderm-committed blastula cells. In mice, enforcing
expression of Pdx1 in pancreatic endocrine progenitor cells results
in increased β cell number and decreased α cell number during
embryonic stages (Yang et al., 2011). As one of the key transcrip-
tion factors required for β cell speciﬁcation and function, Pdx1
enhances transcription of β cell-expressed genes such as Insulin,
Glut2, Glucokinase, and Mafa but inhibits α cell-expressed genes
such as Arx and Glucagon (Gao et al., 2014; Waeber et al., 1996;
Wang et al., 2001). Besides regulating pancreatic progenitor cell
differentiation, Pdx1 has also been shown to directly drive an α to
β cell fate switch. In mouse models, mis-expressing Pdx1 in α cells
drove postnatal conversion of these cells into β cells (Yang et al.,
2011). Moreover, we have previously shown that in zebraﬁsh
models, Pdx1 mis-expressing immature “α-like” cells are unstable,
and can transdifferentiate into β cells (Ye et al., 2015). In the cur-
rent study, we show that loss of insulin during development also
induces the formation of Pdx1þ glucagonþ “α-like” cells. These
“α-like” cells are likely to be the source of increased α to β cell
transdifferentiation after loss of insulin signaling.
3.3. Insulin signaling maintains pluripotency in multiple contexts
Insulin has been classically viewed as a mitogen (Siddle, 2011);
however, insulin also plays key roles in maintaining stem cell fate
and regulating stem cell differentiation (Bendall et al., 2007; Choi
et al., 2011; Shim et al., 2012; Wang et al., 2007). For example, self-
renewal of human embryonic stem (ES) cells requires the activa-
tion of insulin and IGF signal pathways; blocking these signals
promotes ES cell differentiation (Bendall et al., 2007; Wang et al.,
2007). Also, in Drosophila larvae, starvation reduces the number of
hematopoietic progenitor cells by increasing their differentiation,
and these starvation effects are mediated by the insulin signaling
pathway (Shim et al., 2012; Benmimoun et al., 2012). Furthermore,
reduced systemic insulin signaling and down-regulation of the
downstream insulin signaling component Akt/PI3K promotes
hematopoietic and skin stem cell differentiation (Shim et al., 2012;
Sadagurski et al., 2006).
Our study clearly supports a role for insulin in regulating
pancreatic cell differentiation that is similar to the well-described
role of the Notch signaling pathway. Notch sustains Ptf1a expres-
sion in early pancreatic progenitors, stimulates progenitor self-
renewal and blocks endocrine cell differentiation via repression of
the bHLH transcription factor Neurog3 (Lee et al., 2001; Shih et al.,
2012; Ahnfelt-Rønne et al., 2012). Accordingly, disruptions of
Notch signaling induce premature endocrine cell differentiation
and diminish the size of the pancreatic progenitor cell pool (Shih
et al., 2012; Fujikura et al., 2006). The strong phenotypic simila-
rities between the loss of insulin signaling and the loss of Notch
signaling suggest that these pathways interact—that insulin sig-
naling may act as a positive regulator of Notch signaling in pan-
creatic progenitor cells. Indeed, there is evidence that supports
that PI3K/Akt and Notch pathways cross talk: during mega-
karyocyte development the PI3K/AKT pathway is activated by
Notch stimulation, which in turn enhances Notch-dependent dif-
ferentiation (Cornejo et al., 2011). Cooperation between Notch and
insulin signaling may therefore integrate environmental and me-
tabolic cues to regulate progenitor cell maintenance and differ-
entiation. Therefore, it is plausible that insulin signaling in pan-
creatic progenitor cells maintains a positive circuit between PI3K/Akt and Notch that blocks the endocrine differentiation program
and prevents the premature differentiation of β cells. Clearly it will
be important to further clarify the interaction of the notch and
insulin signaling pathways during progenitor differentiation.
Lastly, recent studies have indicated that endogenous pan-
creatic multipotent progenitor cells are present in adult pancreas
both in human (Meier et al., 2006; Patti et al., 2005; Phillips et al.,
2007) and mouse (Xu et al., 2008; Razavi et al., 2015), and that
metabolic stress can inﬂuence their proliferation and differentia-
tion into β cells (Razavi et al., 2015). Maintaining the balance of
self-renewal and differentiation in these progenitor cells is likely
to be crucial for long-term β cell compensation in response to
metabolic stresses. Given our ﬁndings that insulin signaling plays
an important role in regulating progenitor cell differentiation
during development, understanding the roles and mechanisms of
insulin signaling in adult pancreatic progenitors, and how to ap-
propriately manipulate insulin signaling in these populations, may
prove to be critical for developing new regenerative therapies for
diabetes.4. Materials and methods
4.1. Zebraﬁsh maintenance and strains
Zebraﬁsh were raised under standard laboratory conditions at
28 °C. In order to induce dnIRS2-GFP overexpression via the HotCre
system, heat shock activations were performed at 38.5 °C for
20 min at the stages indicated in the text. All animal procedures
were conducted in accordance with OLAW guidelines and were
approved by the Indiana University Institutional Animal Care and
Use Committee. The following transgenic lines were used: Tg
(sox17:GFP)s870 (Sakaguchi et al., 2006), Tg(insa:CFP-NTR)s892 (Cur-
ado et al., 2007), Tg(insa:dsRed)m1018 (Anderson et al., 2009), Tg
(insa:Flag-NTR;cryaa:mCherry)s950 (Andersson et al., 2012), Tg
(neurod:GFP) (Obholzer et al., 2008), Tg(gcga:GFP)ia1 (Pauls et al.,
2007), Tg(gcga:cre; cryaa:YFP)s962 (Ye et al., 2015), Tg(hs:loxp-
mcherry-loxp-H2B-GFP)s925 (Hesselson et al., 2009), Tg(kdrl:GFP)s844
(Jin et al., 2005), Tg(ubi:zebrabow)a131 (Pan et al., 2013), Tg(hs:cre)
(Le et al., 2007) and Tg(hs:loxp-mcherry-loxp-dnIRS2-GFP). To con-
struct the hsp70L-loxP-mCherry-STOP-loxP-dn-irs2a-GFP transgene,
the N-terminus of irs2a was ampliﬁed from BAC DKEYP-24D6
using the oligos: 5′-GGCGC GCCAC CATGG CGAGT CCGCC GCCG
and 5′-CTCGC CCTTG CTCAC CATGG CTGCC ATGCT GTCAG T and
GFP was ampliﬁed from using: 5′-ACTGA CAGCA TGGCA GCCAT
GGTGA GCAAG GGCGA G and 5′-CGAGC TGTAC AAGTA AAGCG
GCCGC. The two resulting products were fused by PCR and cloned
into plasmid hsp70L-loxP-mCherry-STOP-loxP-H2B-GFP_cryaa-cer-
ulean (Addgene #24334) using AscI and NotI; Transgenesis was
performed as described (Hesselson et al., 2009).
4.2. Detection of protein, mRNA and proliferation
Whole mount immunoﬂuorescent staining and western blot-
ting was performed as described before (Anderson et al., 2009).
In situ hybridization and quantitative PCR were used to detect
mRNA expression. In order to detect cell proliferation, an EdU in-
corporation assay was performed as described (Anderson et al.,
2009). The following antibodies were used for immuno-
ﬂuorescence staining: anti-GFP (Aves Labs); anti-insulin (Biome-
da); anti-glucagon (Sigma); anti-dsRed (Clontech); anti-PHH3 (Cell
Signaling); anti-Alcam (Zn-8); anti-Pdx1 (gift of Dr. C. Wright,
Vanderbilt U.). Alexa Fluor-conjugated secondary antibodies were
used for visualization (Life Technologies). For immunoblotting,
anti p-Akt473 (Cell Signaling) was used. The relative expression
level of p-Akt473 was determined by normalizing to α-tublin
Table 2
Primer sets for qPCR analysis.
insa 5′-TCTGC TTCGA GAACA GTGTG
5′-GGAGA GCATT AAGGC CTGTG
insra 5′-CGGCT CGCTG TGTTG TATTG
5′-TACTG TCCCT CCTCT CACGG
insrb 5′-TCGCC TACAT CTTGT GCCTC
5′-AGCTC AAGCC CCTGA AATCC
pdx1 5′-ACACG CACGC ATGGA AAGGA CA
5′-GCGGG CGCGA GATGT ATTTG TT
β-actin 5′-GGCAC GAGAG ATCTT CACTC CCC
5′-GGGGA AAACA GCACG AGGG GC
Table 3
Morpholino Sequences.
Name Target Sequence Dose (ng)
insaMO insa (NM_131056.1) 5′-CCTCT ACTTG ACTTT CTTAC
CCAGA
4
insbMO insb (NM_001039064.1) 5′-AAGTT GGAGA CGTTG
CTCAC CCAGC
2
Sox32MO Sox32(NM_131851.1) 5′-GCATC CGGTC GAGAT
ACATG CTGTT
4
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were used to PCR amplify probe templates from cDNA which were
then synthesized and labeled in vitro using the DIG RNA labeling
kit T7 (Roche). in situ hybridization was performed as described
(Anderson et al., 2009) and color was developed with BM purple
AP Substrate (Roche). For ﬂuorescent in situ hybridization, Vector
Red (Vector Inc.) was used for color develoment. For quantitative
PCR, mRNA was extracted with Trizol (Life Technologies) and re-
verse transcribed with iScript (BioRad). The Mastercycler Realplex
PCR system (Eppendorf) was used with Sybr Green mix and Mytaq
(BioLine) to generate Ct values. The relative expression of each
sample was determined by normalizing to β-actin using the re-
lative standard curve method (Hesselson et al., 2009). The primer
sets in Table 2 were used for quantitative PCR analysis.
4.3. Microinjections
H2B-RFP mRNA, dnIRS2-GFP mRNA, insulin mRNA and sox32
mRNA were transcribed with SP6 mMessage machine kit (In-
vitrogen) in vitro. In order to label the differentiated dorsal pan-
creatic endocrine cells, 100 pg of H2B-RFP mRNA were injected
into zygotes. Immunostaining with anti-dsRed (Clontech) and
Alexa 568 (Life Technologies) antibodies was used to enhance
signal strength. In order to block insulin signaling or to misexpress
insulin, 200 pg dnIRS2-GFP mRNA or 200 pg insulin mRNA were
injected into zygotes, respectively. Immunostaining with anti-GFP
(Aves Labs) and Alexa 488 (Life Technologies) antibodies was used
to enhance the dnIRS2-GFP signal strength. To induce endoderm
differentiation, 200 pg sox32 mRNA were injected into zygotes. To
knockdown gene expression, antisense morpholinos (Gene Tools,
LLC) were injected into zygotes (Table 3): insaMO (4 ng, unless
indicated), insbMO (2 ng, unless indicated) and sox32MO (4 ng).
insaMO and insbMO were designed to bind the exon-intron junc-
tion of the target gene pre-mRNA and disrupt splicing. For as-
sessment of insaMO and insbMO efﬁciency, mRNA was extracted
from 2 dpf control and MO-injected embryos and cDNA was syn-
thesized as described above. The PCR product was then run
through a 1% agarose gel and imaged with Carestream Gel Logic
system. The primers 5′-CATTC CTCGC CTCTG CTTC and 5′-GGAGA
GCATT AAGGC CTGTG were used to assess insaMO efﬁciency and
primer set 5′-CAGAC TCTGC TCACT CAGGA AA and 5′-GCGTG
TAATG GTCAT TTATT GC were used for insbMO. The ampliﬁed
cDNA products were puriﬁed from the gel and sequenced.
4.4. Chemical treatments
For β cell ablations, Tg(insa:CFP-NTR)s892 embryos were in-
cubated in 0.1% DMSO (Sigma)710 mM Metronidazole (MTZ,
sigma) in egg water. After 24 h of treatment, from 54 hpf to 78 hpf,
embryos were washed extensively with fresh egg water, and re-
covered for 1 day. In the mosaic analyses, Tg(insa:Flag-NTR;cryaa:
mCherry)s950 embryos were treated710 mM MTZ from 3 dpf to
4 dpf and MTZ was washed out 2 h prior transplantation. For in-
hibition of the Akt pathway, Tg(insa:CFP-NTR)s892 embryos were
incubated in 0.1% DMSO71 μM wortmannin (Sigma) from 14 hpf
and ﬁxed at 30 hpf or 42 hpf. For inhibition of MAPK pathway, TgTable 1
Primer sets used for synthesis of in situ hybridization probes.
insra 5′-GCTCG TGCGC GTGTT CATAT
5′-GCTAA TACGA CTCAC TATAG GTTTC CGTGG CCTGA GTTC
insrb 5′-GGCTG GACAC ATCTG TGGTT G
5′-GCTAA TACGA CTCAC TATAG GCGGT GGAGG ACAAT TATAT CGTAG
pdx1 5′-GGGAG ACTGC AGGTA GAGCA
5′-GCTAA TACGA CTCAC TATAG GGCCT TTTGC CAATC TGTTT GC(insa:CFP-NTR)s892 were incubated in 0.1%DMSO7100 μM U0126
(Sigma (Hawkins et al., 2008)).
4.5. Cell transplantations
To analyze the roles of insulin signaling in the endoderm, chi-
meric zebraﬁsh embryos were generated by cellular transplanta-
tion (Anderson et al., 2013). sox32 mRNA was synthesized in vitro
and injected (200 pg/embryo) into donor zygotes and 4 ng
sox32MO was injected into host zygotes to promote the endoderm
replacement by donor cells. Tg(sox17:GFP)s870 donor embryos were
used to distinguish the transplanted endoderm. To analyze the
differentiation of blastomeres in zebraﬁsh host larvae, Tg(sox17:
GFP)s870 donor embryos were injected with 200 pg sox32 mRNA
alone or together with 200 pg dnIRS2-GFP mRNA. De-chorionated
donor blastulae were immobilized in agarose molds and 4 dpf host
larvae were immobilized with 2% methylcellulose. About 20–40
cells were extracted from the donor and injected into host larvae
in the abdominal cavity behind the liver and above the pancreas.
To examine blood vessel inﬁltration of transplanted donor tissue,
Tg(ubi:zebrabow)a131 donor embryos were injected with 200 pg
sox32 mRNA and transplanted into 4 dpf Tg(kdrl:GFP)s844 host
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